Questions? Call 800-624-6242
add to cart
Rights & Permissions
. "Appendix A: Workshop Agenda." Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary. Washington, DC: The National Academies Press, 2009.
Please select a format:
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Biomarkers for Psychiatric Drug Toxicity: Opportunities and Challenges
National Institute of Mental Health
Panel Discussion—Integration of New Science into Drug Safety Prediction and Assessment
How can we develop more efficient approaches to biomarker evaluation and qualification in animals and humans?
What potential policies could be enacted to help guide this effort?
How could these efforts be advanced through public or private means?